Featured Research

from universities, journals, and other organizations

Effects of chemoradiation therapy by using capecitabine on gastric cancer patients

Date:
September 20, 2010
Source:
World Journal of Gastroenterology
Summary:
A research team from Singapore reviewed the outcome of patients with resected gastric cancers treated with capecitabine and radiation compared to 5-fluorouracil with radiation or fluoropyrimidine-based chemotherapy only. They found that survival of patients treated with capecitabine and radiation was comparable to the other two conventional treatments.

Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined. The most common strategies in the adjuvant treatment of gastric cancers include fluoropyrimidine-based chemotherapy with or without radiation. The introduction of capecitabine has largely replaced continuous-infusion 5-fluorouracil (5-FU) owing to its ease of administration. However, its efficacy is not proven in randomized phase III trials involving gastric cancers.

Related Articles


A research article published on August 7, 2010 in the World Journal of Gastroenterology addresses this question. In this retrospective review study, the authors examined the role of capecitabine with radiation and compared its efficacy to the 5-FU with radiation regimen and fluoropyrimidinebased chemotherapy alone.

This study showed that capecitabine with concurrent radiation was as effective as 5-FU with radiation or fluoropyrimidine-based chemotherapy alone without radiation when given as adjuvant treatment for locally advanced gastric cancer.

The result from this hypothesis-generating study provides the basis for a further prospective study in evaluating the role of radiation with concurrent capecitabine as adjuvant therapy in resected gastric cancers.


Story Source:

The above story is based on materials provided by World Journal of Gastroenterology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Tham CK, Choo SP, Poon DYH, Toh HC, Ong SYK, Tan SH, Wang MLC, Foo KF. Capecitabine with radiation is an effective adjuvant therapy in gastric cancers. World Journal of Gastroenterology, 2010; 16 (29): 3709 DOI: 10.3748/wjg.v16.i29.3709

Cite This Page:

World Journal of Gastroenterology. "Effects of chemoradiation therapy by using capecitabine on gastric cancer patients." ScienceDaily. ScienceDaily, 20 September 2010. <www.sciencedaily.com/releases/2010/09/100920111340.htm>.
World Journal of Gastroenterology. (2010, September 20). Effects of chemoradiation therapy by using capecitabine on gastric cancer patients. ScienceDaily. Retrieved December 29, 2014 from www.sciencedaily.com/releases/2010/09/100920111340.htm
World Journal of Gastroenterology. "Effects of chemoradiation therapy by using capecitabine on gastric cancer patients." ScienceDaily. www.sciencedaily.com/releases/2010/09/100920111340.htm (accessed December 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Weirdest Health Studies Of 2014

The Weirdest Health Studies Of 2014

Newsy (Dec. 27, 2014) One of this year's strangest studies found people prefer painful electric shocks to being alone with their thoughts. Video provided by Newsy
Powered by NewsLook.com
Healthier Lifestyles Could Prevent 4 In 10 Cancer Cases

Healthier Lifestyles Could Prevent 4 In 10 Cancer Cases

Newsy (Dec. 26, 2014) If patients had led healthier lifestyles, Cancer Research UK found about 40 percent of cancer cases could have been prevented. Video provided by Newsy
Powered by NewsLook.com
When Healthy Eating Becomes Dangerous

When Healthy Eating Becomes Dangerous

Newsy (Dec. 26, 2014) Experts say fad diets can lead to orthorexia, a disorder that can cause physical and emotional distress. Video provided by Newsy
Powered by NewsLook.com
FDA Issues New Warning About Pure Caffeine Powder Usage

FDA Issues New Warning About Pure Caffeine Powder Usage

Newsy (Dec. 24, 2014) The FDA cites two deaths this year linked to pure caffeine powder as warnings of the potentially fatal substance. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins